Company intelligence / Profile preview

ODAIA

Toronto, Ontario, Canada

Ownership: Private
Employees: ~94
Development stage: Other

Overview

ODAIA does not develop specific therapeutic products but provides AI-powered predictive analytics and commercial insights to pharmaceutical companies, supporting the commercialization strategy and optimizing engagement with healthcare providers. Their solutions help clients accelerate time-to-therapy and improve brand performance through the MAPTUAL platform, which is used to manage dozens of therapeutic products across major pharma clients.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on ODAIA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ODAIA.

Explore the full profile